Filing Details
- Accession Number:
- 0001209191-17-052804
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-14 16:09:19
- Reporting Period:
- 2017-09-12
- Accepted Time:
- 2017-09-14 16:09:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1614018 | Mark Vachon | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-09-12 | 6,000 | $30.47 | 8,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-09-12 | 1,270 | $126.15 | 6,730 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-09-12 | 4,730 | $127.00 | 2,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2017-09-12 | 6,000 | $0.00 | 6,000 | $30.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,000 | 2024-07-16 | No | 4 | M | Direct |
Footnotes
- the sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2017.
- The range in prices for the transaction reported on this line was $125.65 to $126.60. The average weighted price was $126.1469. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $126.65 to $127.35. The average weighted price was $127.0013. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests ratably over three years in annual installments, commencing on July 16, 2014.
Billionaire Hedge Funds
